INCY
INCY
NASDAQ · Biotechnology

Incyte Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$104.40
+0.74 (+0.71%)
As of Jun 23, 9:39 PM ET ·
Analyst Consensus
Hold
35
Analysts
Very High
Coverage
Buy 16 46%
Hold 18 51%
Sell 1 3%
Price Target
Analyst Price Target +98.1% upside
Low Target $125.25
Average Target $206.81
High Target $260.19
Current Price $104.40
Current
$104.40
Target
$206.81
$125.25 $206.81 avg $260.19
Scenario Analysis
Bear Case
$125.25
20.0%
Low target
Base Case
$206.81
+98.1%
Avg target
Bull Case
$260.19
+149.2%
High target
Risk/Reward
7.5x
Highly favorable
Price in Context
52-Week High
$112.29
-7.0% from high
52-Week Low
$66.74
+56.4% from low
50-Day SMA
$101.74
+2.6% vs SMA
200-Day SMA
$86.15
+21.2% vs SMA
RSI (14)
51.1
Neutral
Target vs 52W High
$206.81
+84.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%